PACAX
Price
$11.35
Change
-$0.00 (-0.00%)
Updated
Sep 16 closing price
Net Assets
580.37M
QBDAX
Price
$8.50
Change
-$0.00 (-0.00%)
Updated
Sep 16 closing price
Net Assets
88.48M
Interact to see
Advertisement

PACAX vs QBDAX

Header iconPACAX vs QBDAX Comparison
Open Charts PACAX vs QBDAXBanner chart's image
Putnam Dynamic Asset Allocation Cnsrv A
Price$11.35
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets580.37M
Quantified Managed Income Advisor
Price$8.50
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets88.48M
PACAX vs QBDAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PACAX vs. QBDAX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACAX is a Buy and QBDAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PACAX has more cash in the bank: 580M vs. QBDAX (88.5M). PACAX pays higher dividends than QBDAX: PACAX (3.40) vs QBDAX (3.13). PACAX was incepted earlier than QBDAX: PACAX (32 years) vs QBDAX (10 years). QBDAX (2.26) is less costly to investors than PACAX (1.00). QBDAX is a more actively managed with annual turnover of: 718.00 vs. PACAX (372.00). PACAX has a lower initial minimum investment than QBDAX: PACAX (0) vs QBDAX (10000). PACAX annual gain was more profitable for investors over the last year : 5.85 vs. QBDAX (2.18). PACAX return over 5 years is better than : 12.22 vs. QBDAX (0.05).
PACAXQBDAXPACAX / QBDAX
Total Expense Ratio1.002.2644%
Annual Report Gross Expense Ratio1.002.2644%
Fund Existence32 years10 years-
Gain YTD9.1555.590164%
Front Load6%N/A-
Min. Initial Investment010000-
Min. Initial Investment IRAN/AN/A-
Net Assets580M88.5M655%
Annual Yield % from dividends3.403.13109%
Returns for 1 year5.852.18268%
Returns for 3 years24.624.83510%
Returns for 5 years12.220.0523,100%
Returns for 10 years29.82N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RCGHX15.13N/A
N/A
Virtus KAR Health Sciences C
NMAVX12.34N/A
N/A
Nuance Mid Cap Value Investor
MDODX11.85N/A
N/A
Morgan Stanley Developing Opportunity R6
RAPAX11.15N/A
N/A
Cohen & Steers Real Assets A
JANIX27.71-0.03
-0.11%
Janus Henderson Triton D